Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site.
Year: 1999
Type: article
Source: PubMed
Authors: B K Halak, H C Maguire, E C Lattime
Institutions: Thomas Jefferson University, Sidney Kimmel Cancer Center
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2137745956
